Traws Pharma, Inc. financial data

Symbol
TRAW on Nasdaq
Location
12 Penns Trail, Newtown, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 185 % -0.16%
Return On Equity 415 %
Return On Assets -73.9 %
Operating Margin -698 % +98.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.99M shares +164%
Common Stock, Shares, Outstanding 7.13M shares +136%
Entity Public Float 9.6M USD -61%
Common Stock, Value, Issued 71K USD +137%
Weighted Average Number of Shares Outstanding, Basic 8.82M shares +817%
Weighted Average Number of Shares Outstanding, Diluted 8.82M shares +817%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.9M USD +1185%
Revenue from Contract with Customer, Excluding Assessed Tax 57K USD 0%
Research and Development Expense 9.26M USD -31.3%
General and Administrative Expense 9.67M USD -11.3%
Operating Income (Loss) -15.8M USD +88.8%
Net Income (Loss) Attributable to Parent -13.3M USD +53.3%
Earnings Per Share, Basic -5 USD/shares +87.5%
Earnings Per Share, Diluted -5 USD/shares +87.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.6M USD -46.6%
Other Assets, Current 92K USD -73.5%
Assets, Current 9.63M USD +7.87%
Property, Plant and Equipment, Net 7K USD -41.7%
Other Assets, Noncurrent 240K USD +23900%
Assets 12.4M USD +39.2%
Accounts Payable, Current 5.11M USD -6.71%
Employee-related Liabilities, Current 774K USD +33.9%
Accrued Liabilities, Current 2.78M USD +4.98%
Contract with Customer, Liability, Current 226K USD 0%
Liabilities, Current 7.89M USD -5.52%
Contract with Customer, Liability, Noncurrent 2.51M USD -8.3%
Liabilities 7.9M USD -28%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6K USD
Retained Earnings (Accumulated Deficit) -633M USD -2.15%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.55M USD
Liabilities and Equity 12.4M USD +39.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.44M USD -22.9%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 7.13M shares +136%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.4M USD -21.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.42M USD +18.7%
Deferred Tax Assets, Valuation Allowance 36.8M USD -78.9%
Deferred Tax Assets, Gross 36.8M USD -78.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.3M USD +53.2%
Property, Plant and Equipment, Gross 84K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 28.3M USD -61.7%
Preferred Stock, Shares Issued 7.44K shares 0%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 6.74K shares -9.45%
Amortization of Intangible Assets 14K USD
Depreciation, Depletion and Amortization 1K USD -75%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 735K USD -47%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%